loadpatents
name:-0.050359010696411
name:-0.025786876678467
name:-0.0081748962402344
KIM; Jong-Mook Patent Filings

KIM; Jong-Mook

Patent Applications and Registrations

Patent applications and USPTO patent grants for KIM; Jong-Mook.The latest application filed is for "intron fragments".

Company Profile
6.24.32
  • KIM; Jong-Mook - Seoul KR
  • Kim; Jong Mook - Incheon KR
  • Kim; Jong-Mook - Yongin-shi KR
  • Kim; Jong-mook - Incheon-city KR
  • Kim, Jong-Mook - Kyungki-do KR
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Intron Fragments
App 20220010332 - KONG; Hoon Young ;   et al.
2022-01-13
Adeno-associated Virus (aav) Delivery Of Anti-fam19a5 Antibodies
App 20210388382 - KIM; Jong-Mook ;   et al.
2021-12-16
Cosmetic composition for wrinkle reduction containing gypenoside isolated from Gynostemma pentaphyllum
Grant 11,007,136 - Park , et al. May 18, 2
2021-05-18
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
Grant RE48,404 - Kim , et al. January 26, 2
2021-01-26
Gene Therapy For Diabetic Neuropathy Using An Hgf Isoform
App 20200354420 - KIM; Jong Mook ;   et al.
2020-11-12
Gene therapy for diabetic neuropathy using an HGF isoform
Grant 10,759,841 - Kim , et al. Sep
2020-09-01
Gene Therapy For Diabetic Neuropathy Using An Hgf Isoform
App 20190241632 - KIM; Jong Mook ;   et al.
2019-08-08
Cosmetic Composition For Wrinkle Reduction Containing Gypenoside Isolated From Gynostemma Pentaphyllum
App 20190110980 - Park; Young Jun ;   et al.
2019-04-18
Gene Therapy For Diabetic Neuropathy Using An Hgf Isoform
App 20180222955 - KIM; Jong Mook ;   et al.
2018-08-09
Gene therapy for diabetic neuropathy using an HGF isoform
Grant 9,963,493 - Kim , et al. May 8, 2
2018-05-08
Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
Grant 9,834,594 - Chang , et al. December 5, 2
2017-12-05
Human Monoclonal Antibodies Derived From Human B Cells And Having Neutralizing Activity Against Influenza A Viruses
App 20170158754 - Chang; Shin Jae ;   et al.
2017-06-08
Human monoclonal antibodies derived from human B cells and having neutralizing activity against influenza A viruses
Grant 9,573,991 - Chang , et al. February 21, 2
2017-02-21
Method for selecting a high expression recombinant cell line
Grant 9,309,519 - Cho , et al. April 12, 2
2016-04-12
Gene Therapy For Diabetic Neuropathy Using An Hgf Isoform
App 20140296142 - Kim; Jong Mook ;   et al.
2014-10-02
Expression vector for animal cell comprising at least one copy of MAR DNA sequences at the 3' terminal of transcription termination region of a gene and method for the expression of foreign gene using the vector
Grant 8,772,021 - Kim , et al. July 8, 2
2014-07-08
Lyophilized DNA formulations for enhanced expression of plasmid DNA
Grant 8,389,492 - Kim , et al. March 5, 2
2013-03-05
Human Monoclonal Antibodies Derived From Human B Cells And Having Neutralizing Activity Against Influenza A Viruses
App 20130004505 - Chang; Shin Jae ;   et al.
2013-01-03
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
Grant 8,338,385 - Kim , et al. December 25, 2
2012-12-25
Compositions and methods for fusion protein separation
Grant 8,106,158 - Kim , et al. January 31, 2
2012-01-31
Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor
App 20120010273 - KIM; Jong-Mook ;   et al.
2012-01-12
Method For Selecting A High Expression Recombinant Cell Line
App 20120009682 - Cho; MyungSam ;   et al.
2012-01-12
Lyophilized Dna Formulations For Enhanced Expression Of Plasmid Dna
App 20110166211 - KIM; JONG-MOOK ;   et al.
2011-07-07
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
Grant 7,838,505 - Kim , et al. November 23, 2
2010-11-23
Compositions and Methods for Fusion Protein Separation
App 20100285526 - KIM; Sujeong ;   et al.
2010-11-11
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
Grant 7,812,146 - Kim , et al. October 12, 2
2010-10-12
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
Grant 7,745,174 - Kim , et al. June 29, 2
2010-06-29
Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor
App 20100105878 - Kim; Jong-Mook ;   et al.
2010-04-29
Lyophilized DNA Formulations for Enhanced Expression of Plasmid DNA
App 20090258932 - KIM; JONG-MOOK ;   et al.
2009-10-15
Compositions and methods for fusion protein separation
Grant 7,585,943 - Kim , et al. September 8, 2
2009-09-08
Treatment and Prevention of Cardiac Conditions Using Two or More Isoforms of Hepatocyte Growth Factor
App 20090202606 - Kim; Jong-Mook ;   et al.
2009-08-13
Hybrid Hepatocyte Growth Factor Gene Having High Expression Efficiency of Two Heterotypes of Hepatocyte Growth Factor
App 20090131350 - Kim; Jong-Mook ;   et al.
2009-05-21
Expression vector for animal cell
Grant 7,422,874 - Kim , et al. September 9, 2
2008-09-09
Compositions and methods for fusion protein separation
App 20080171852 - Kim; Sujeong ;   et al.
2008-07-17
Expression Vector for Animal Cell Comprising at Least One Copy of Mar Dna Sequences at the 3'Terminal of Transcription Termination Region of a Gene and Method for the Expression of Foreign Gene Using the Vector
App 20080102523 - Kim; Jong-mook ;   et al.
2008-05-01
Low Dose Treatment with an Interleukin-11 Analog
App 20080069796 - Kim; Jong-Mook ;   et al.
2008-03-20
Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
Grant 7,175,840 - Kim , et al. February 13, 2
2007-02-13
Compositions and methods for fusion protein separation
App 20060276625 - Kim; Sujeong ;   et al.
2006-12-07
Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
App 20060198826 - Kim; Jong-Mook ;   et al.
2006-09-07
Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
App 20060193833 - Kim; Jong-Mook ;   et al.
2006-08-31
Compositions for gene therapy of rheumatoid arthritis including a gene encoding an anti-angiogenic protein or parts thereof
App 20050277603 - Kim, Jong-Mook ;   et al.
2005-12-15
Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
App 20050079581 - Kim, Jong-Mook ;   et al.
2005-04-14
Construction of high efficiency retroviral vector for gene therapy of hunter syndrome
Grant 6,838,280 - Kim , et al. January 4, 2
2005-01-04
Electro-gene therapy of arthritis by using an expression plasmid encoding the soluble p75 tumor necrosis factor receptor-Fc fusion protein
App 20040082533 - Kim, Jong-Mook ;   et al.
2004-04-29
Expression vector using for animal cell
App 20040038394 - Kim, Jong-Mook ;   et al.
2004-02-26
Retrovirus-specific oligonucleotides and a method for measuring retroviral titer using same
App 20030175698 - Kim, Jong-Mook ;   et al.
2003-09-18
Construction of high efficiency retroviral vector for gene therapy of hunter syndrome
App 20030165469 - Kim, Sunyoung ;   et al.
2003-09-04
Gene therapy composition for treating viral myocarditis
App 20030139367 - Jeon, Eun-Seok ;   et al.
2003-07-24
Gene therapy composition for treating arthritis
App 20030130223 - Kim, Jong-Mook ;   et al.
2003-07-10
High efficiency retroviral vectors that contain none of viral coding sequences
Grant 6,451,595 - Kim , et al. September 17, 2
2002-09-17

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed